Recall issued for heartburn medicine

News
recall generic_1466525419134.jpg

(CNN) – Drugmaker Sandoz is recalling a heartburn medication in the US due to contamination with NDMA, a probable carcinogen.

The medication is Ranitidine Hydrochloride.

Sandoz said it hasn’t gotten any reports of adverse events related to product contamination.

Its parent company, Novartis, said last week that it was stopping the distribution of all the medicine.

Novartis called the measure ‘precautionary.’

Another company makes Ranitidine medication sold under the brand name Zantac but that is not being recalled.

For the latest breaking news and stories from across the Tri-State, follow Eyewitness News on Facebook and Twitter.

(This story was originally published on September 25, 2019)

Copyright 2019 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.